Actively Recruiting

Age: 1Day - 28Days
All Genders
NCT06768008

An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease

Led by Beijing Anzhen Hospital · Updated on 2025-01-10

10000

Participants Needed

1

Research Sites

469 weeks

Total Duration

On this page

Sponsors

B

Beijing Anzhen Hospital

Lead Sponsor

C

Capital Institute of Pediatrics, China

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this two-way cohort study was to explore whether an integrated prenatal and postnatal treatment model for neonates with critical congenital heart disease (CCHD) could be effective in avoiding preoperative morbidities, creating an ideal timing for surgery, thereby reducing postoperative in-hospital mortality, and improving surgical prognosis compared with the traditional model of care. In addition, in neonates with CCHD associated with the right cardiac system, the investigators aim to further investigate whether early postnatal cardiac surgery has the potential advantage of obtaining a time window for myocardial regeneration and thus improving myocardial remodeling. The aim of this study is to improve the diagnostic and therapeutic capacity of critical congenital heart disease and to promote the integrated prenatal-postnatal treatment model for clinical use. This will ultimately improve the quality of healthcare services for patients with cardiovascular diseases and lay the foundation for exploring guidelines for the treatment of cardiovascular diseases suitable for China's national conditions. The project will be jointly implemented by Beijing Anzhen Hospital , Capital Pediatric Research Institute, and 307 PLA General Hospital. Starting from January 1, 2022, the hospitals will continue to collect hospitalized cases of newborns with CCHD. The integrated prenatal and postnatal model is defined as a definitive diagnosis of CCHD in the fetal period (22-26 weeks), documentation of intrauterine transfer in our obstetrics department, subsequent initiation of an intrapartum or postpartum surgical plan after multidisciplinary consultation, and transfer to the pediatric heart center at the first hour of life, where the child is treated with either postpartum immediate or elective surgery, depending on patient status. For neonates who meet the indications for emergency surgery, surgery is performed immediately after birth. For neonates with non-emergency surgical indications, surgery is performed after birth adjustment to optimal status. The traditional model was defined as postpartum transfer via an outside hospital with routine interventions. The investigators then evaluate surgical prognosis and myocardial regenerative capacity to compare the effects of the two treatment models. This project will validate the advantages of an integrated prenatal and postnatal model over traditional models through real-world research and will improve prognosis in neonates with CCHD.

CONDITIONS

Official Title

An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease

Who Can Participate

Age: 1Day - 28Days
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Full-term infants (gestational age 37-40 weeks) younger than 28 days
  • Preterm infants (gestational age >32 weeks but <37 weeks) with corrected gestational age in neonatal period, younger than 28 days
  • Birth weight greater than 1.5 kg
  • Fetal diagnosis of congenital heart disease by ultrasound at 22-26 weeks of gestation suitable for biventricular repair
Not Eligible

You will not qualify if you...

  • Suitable only for palliative surgery or single ventricle repair
  • Presence of genetic or chromosomal abnormalities
  • Presence of other severe systemic diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Biejing Anzhen Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

L

Lizhi Lv, MD

CONTACT

Q

Qiang Wang, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here